Skip to main content
NEPTinactive

Neptune Wellness Solutions Inc.

·Commercial

NEPT evidence brief

What we can confirm

No verified snapshot fields are available yet.

What it means

The company data is ready for cross-source review; unsupported conclusions remain unknown.

What to watch

Watch the next source-backed data update.
BioSniper AIPage evidence connected

Prepared research question

What matters most for NEPT—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

7.3/10

BioSniper Score

Based on 4 of 6 signals

Market Cap

Cash Runway

Lead Asset

maxsimil (Approved)

Next Catalyst

Financial data as of Dec 31, 2023.

Tracking 1 pipeline candidate for Neptune Wellness Solutions Inc..

Run Neptune Wellness Solutions Inc. through your own thesis

Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.

Your protocol can:

  • Turn available Neptune Wellness Solutions Inc. facts into screen rules or deeper checks
  • Show cited findings, blockers, and unresolved evidence together
  • Save the logic and rerun it as the company evidence changes
Run a thesis on this company — freeRun a thesis on this company

Score breakdownBased on 4 of 6 signals · derived from public data

Cash Runway10.0

Profitable (positive operating cash flow)

Financial Health6.0

OCF $21M · Net income -$18M · Debt/OCF 0.6×

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Pipeline

Financials

925 companies232,681 SEC filings21,419 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.